Thus, in the ESRD group of patients with ACD, we found significantly increased serum iron, transferrin saturation, and MCV, as well as decreased TIBC, transferrin levels, and soluble transferrin receptor levels. The gene discussed is TFRC; the disease is granular corneal dystrophy type II.